More recently Vakrakou et al. demonstrated that SS patients at high risk for lymphoma development, as well as SS patients that have developed lymphoma, displayed a unique NLRP3 inflammasome gene signature in peripheral blood mononuclear cells and increased levels of IL-18 [135]. This evidence concerns the gene IL18 and synovial sarcoma.